Co-amoxiclav pharmacokinetics during posttraumatic hemorrhagic shock

Crit Care Med. 2001 Jul;29(7):1350-5. doi: 10.1097/00003246-200107000-00009.

Abstract

Objective: To determine the effects of severe trauma with hemorrhagic shock on amoxicillin and clavulanate concentrations in plasma and their pharmacokinetics.

Design: A prospective, open, descriptive study.

Setting: A 12-bed, adult surgical intensive care unit in a university-affiliated hospital in France.

Subjects: Subjects were 12 patients (10 men, 2 women) with severe trauma: median (range) Injury Severity Score, 38 (17-48); Acute Physiology and Chronic Health Evaluation II, 16 (7-38); Simplified Acute Physiology Score II, 41 (23-77). Also enrolled were 12 healthy volunteers who were matched on age (+/-5 yrs), gender, and body-surface area (+/-20 cm2). All the trauma patients suffered hemorrhagic shock defined as the association of at least one episode of systolic blood pressure <90 mm Hg and an intravascular volume expansion >2000 mL between trauma and surgery.

Intervention: Prophylactic perioperative administration of 2 g of amoxicillin and 0.2 g of clavulanate in combination during the first 12 hrs posttrauma in patients, and at the start of the pharmacokinetic study in volunteers.

Measurements and main results: Serial plasma samples (n = 13) were obtained after the first antibiotic administration to measure antibiotic levels by using high-performance liquid chromatography assays. Compared with volunteers, trauma patients had higher plasma amoxicillin and clavulanate concentrations, attributed to a reduction of the volume of distribution (p =.001 and p =.06, respectively) and, to a lesser extent, of the total body clearance (p =.09 and p =.20, respectively). Consequently, amoxicillin and clavulanate elimination half-lives were similar for the two groups of subjects. The interindividual variabilities for all the amoxicillin pharmacokinetic parameters were higher in patients.

Conclusions: In trauma patients with hemorrhagic shock requiring surgery, the administration of 2 g of amoxicillin and 0.2 g of clavulanate seems adequate, according to the antibiotic concentrations observed in plasma for both drugs. However, further studies exploring antibiotic concentrations in tissues are warranted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APACHE
  • Adolescent
  • Adult
  • Amoxicillin-Potassium Clavulanate Combination / pharmacokinetics*
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Anti-Bacterial Agents / pharmacokinetics*
  • Anti-Bacterial Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination / pharmacokinetics*
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Infusions, Intravenous
  • Injury Severity Score
  • Intraoperative Care
  • Male
  • Middle Aged
  • Prospective Studies
  • Regional Blood Flow
  • Shock, Hemorrhagic / drug therapy*
  • Shock, Traumatic / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination